Peter C.  Farrell net worth and biography

Peter Farrell Biography and Net Worth

Director of ResMed

Peter Farrell is ResMed’s founder and chair emeritus. He has been a director since ResMed’s inception in May 1989, and served as the chair of our board of directors until January 2023, when he became chair emeritus. Dr. Farrell served as CEO from July 1990 until December 2007, and from February 2011 until March 2013. He served as executive board chairman from December 2007 until February 2011, and from March 2013 through December 2013. Since January 1, 2014, he has been a non-officer employee of ResMed.

Before founding ResMed, Dr. Farrell served as vice president of research and development at various subsidiaries of Baxter International, Inc. (NYSE: BAX), from July 1984 to June 1989, and managing director of the Baxter Center for Medical Research Pty Ltd., a Baxter subsidiary, from August 1985 to June 1989. From January 1978 to December 1989, he was foundation director of the Graduate School for Biomedical Engineering at the University of New South Wales, where he currently serves as a visiting professor and was formerly chair of the UNSW Centre for Innovation and Entrepreneurship. He served on the Visiting Committee of the Harvard/MIT Health Sciences & Technology Program from 1998 through 2018, and currently serves on the MIT Dean of Engineering’s Advisory Council.

Dr. Farrell serves on two additional public company boards: Arcturus Therapeutics Ltd (NASDAQ: ARCT), a self-replicating mRNA therapeutics company, as board chair and member of its compensation and nominating and governance committees; and Evolus, Inc. (NASDAQ: EOLS), a performance beauty company, as member of its audit and nominating and governance committees.

Dr. Farrell also serves on the board of three privately held companies: Immunicom Inc., a medtech company developing blood-filtering Immunopheresis® technology to treat cancer and other terminal diseases; ProtoStar, a medical rehabilitation company; and WaveGuide, a startup leveraging nuclear magnetic resonance technology developed within Harvard’s School of Physics, as its chair.

Finally, Dr. Farrell sits on the Board of Trustees of Scripps Research, and on two faculty advisory boards at the University of California, San Diego: the Rady Business School and the Jacobs Engineering School.

Dr. Farrell is a fellow or honorary fellow of several professional bodies. In 2012, he became an elected member of the U.S. National Academy of Engineering and joined the board of trustees of Scripps Research. He was named 2005 U.S. National Entrepreneur of the Year for Health Sciences, 2001 Australian Entrepreneur of the Year, and 1998 San Diego Entrepreneur of the Year for Health Sciences. He has served on the Executive Council of the Division of Sleep Medicine at Harvard Medical School since 1998, served as vice-chairman from 2000 until 2010, and chairman until May 2013.

Dr. Farrell has a B.E. in chemical engineering with honors from the University of Sydney, an S.M. in chemical engineering from MIT, a Ph.D. in chemical engineering and bioengineering from the University of Washington, Seattle, and a D.Sc. from the University of New South Wales, Sydney, for research contributions in the field of treatment with the artificial kidney.

What is Peter C. Farrell's net worth?

The estimated net worth of Peter C. Farrell is at least $32.42 million as of February 22nd, 2024. Dr. Farrell owns 157,404 shares of ResMed stock worth more than $32,418,928 as of May 30th. This net worth approximation does not reflect any other assets that Dr. Farrell may own. Additionally, Dr. Farrell receives a salary of $430,210.00 as Director at ResMed. Learn More about Peter C. Farrell's net worth.

How old is Peter C. Farrell?

Dr. Farrell is currently 82 years old. There are 4 older executives and no younger executives at ResMed. Learn More on Peter C. Farrell's age.

What is Peter C. Farrell's salary?

As the Director of ResMed Inc., Dr. Farrell earns $430,210.00 per year. There are 4 executives that earn more than Dr. Farrell. The highest earning executive at ResMed is Mr. Michael J. Farrell BE, MBA, SM, CEO & Chairman, who commands a salary of $2,870,000.00 per year. Learn More on Peter C. Farrell's salary.

How do I contact Peter C. Farrell?

The corporate mailing address for Dr. Farrell and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on Peter C. Farrell's contact information.

Has Peter C. Farrell been buying or selling shares of ResMed?

Peter C. Farrell has not been actively trading shares of ResMed within the last three months. Most recently, Peter C. Farrell sold 10,935 shares of the business's stock in a transaction on Thursday, February 22nd. The shares were sold at an average price of $182.66, for a transaction totalling $1,997,387.10. Following the completion of the sale, the director now directly owns 157,404 shares of the company's stock, valued at $28,751,414.64. Learn More on Peter C. Farrell's trading history.

Who are ResMed's active insiders?

ResMed's insider roster includes Carol Burt (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.

Are insiders buying or selling shares of ResMed?

In the last twelve months, insiders at the medical equipment provider sold shares 23 times. They sold a total of 70,837 shares worth more than $13,371,821.12. The most recent insider tranaction occured on May, 15th when Director Witte Jan De sold 360 shares worth more than $78,584.40. Insiders at ResMed own 1.2% of the company. Learn More about insider trades at ResMed.

Information on this page was last updated on 5/15/2024.

Peter C. Farrell Insider Trading History at ResMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
2/22/2024Sell10,935$182.66$1,997,387.10157,404View SEC Filing Icon  
10/31/2022Sell9,050$221.98$2,008,919.00183,052View SEC Filing Icon  
11/9/2017Sell118,392$82.70$9,791,018.40306,615View SEC Filing Icon  
11/6/2017Sell20,000$83.53$1,670,600.00314,800View SEC Filing Icon  
10/4/2017Sell20,000$77.01$1,540,200.00View SEC Filing Icon  
9/5/2017Sell20,000$76.74$1,534,800.00314,800View SEC Filing Icon  
8/4/2017Sell20,000$75.15$1,503,000.00321,557View SEC Filing Icon  
7/5/2017Sell20,000$76.50$1,530,000.00321,557View SEC Filing Icon  
6/5/2017Sell20,000$72.65$1,453,000.00321,557View SEC Filing Icon  
5/4/2017Sell20,000$68.75$1,375,000.00321,557View SEC Filing Icon  
4/4/2017Sell20,000$70.67$1,413,400.00321,557View SEC Filing Icon  
2/6/2017Sell20,000$68.32$1,366,400.00321,557View SEC Filing Icon  
1/4/2017Sell20,000$62.14$1,242,800.00321,557View SEC Filing Icon  
12/5/2016Sell20,000$59.83$1,196,600.00372,407View SEC Filing Icon  
11/4/2016Sell20,000$57.28$1,145,600.00367,978View SEC Filing Icon  
10/4/2016Sell20,000$64.70$1,294,000.00364,063View SEC Filing Icon  
9/6/2016Sell20,000$67.29$1,345,800.00367,978View SEC Filing Icon  
8/4/2016Sell20,000$69.16$1,383,200.00367,978View SEC Filing Icon  
7/7/2016Sell20,000$63.62$1,272,400.00367,978View SEC Filing Icon  
6/6/2016Sell20,000$59.82$1,196,400.00367,978View SEC Filing Icon  
5/4/2016Sell20,000$55.90$1,118,000.00367,978View SEC Filing Icon  
4/4/2016Sell20,000$57.51$1,150,200.00367,978View SEC Filing Icon  
3/4/2016Sell20,000$57.51$1,150,200.00367,978View SEC Filing Icon  
2/25/2016Sell139,980$57.31$8,022,253.80347,978View SEC Filing Icon  
2/4/2016Sell20,000$57.70$1,154,000.00347,978View SEC Filing Icon  
1/4/2016Sell20,000$52.22$1,044,400.00347,978View SEC Filing Icon  
10/1/2015Sell27,169$50.93$1,383,717.17289,826View SEC Filing Icon  
9/1/2015Sell36,000$50.82$1,829,520.00289,826View SEC Filing Icon  
7/1/2015Sell36,000$55.61$2,001,960.00View SEC Filing Icon  
6/1/2015Sell36,000$59.25$2,133,000.00View SEC Filing Icon  
4/1/2015Sell36,000$70.70$2,545,200.00View SEC Filing Icon  
3/2/2015Sell36,000$64.64$2,327,040.00View SEC Filing Icon  
2/2/2015Sell36,000$61.97$2,230,920.00View SEC Filing Icon  
1/2/2015Sell36,000$56.99$2,051,640.00View SEC Filing Icon  
12/1/2014Sell36,000$53.28$1,918,080.00View SEC Filing Icon  
11/18/2014Sell36,000$52.39$1,886,040.00View SEC Filing Icon  
10/29/2014Sell119,204$51.84$6,179,535.36View SEC Filing Icon  
8/1/2014Sell25,000$49.04$1,226,000.00View SEC Filing Icon  
7/1/2014Sell25,000$50.09$1,252,250.00View SEC Filing Icon  
6/2/2014Sell25,000$49.57$1,239,250.00View SEC Filing Icon  
10/1/2013Sell25,000$53.21$1,330,250.00View SEC Filing Icon  
9/5/2013Sell25,000$48.00$1,200,000.00View SEC Filing Icon  
See Full Table

Peter C. Farrell Buying and Selling Activity at ResMed

This chart shows Peter C Farrell's buying and selling at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ResMed Company Overview

ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $205.96
Low: $205.01
High: $207.74

50 Day Range

MA: $201.16
Low: $173.86
High: $220.63

2 Week Range

Now: $205.96
Low: $132.24
High: $229.97

Volume

598,023 shs

Average Volume

1,012,940 shs

Market Capitalization

$30.26 billion

P/E Ratio

31.64

Dividend Yield

0.90%

Beta

0.64